£76.38

Springer Biologie und Epidemiologie der Hormonersatztherapie - Biology and Epidemiology of Hormone Replacement Therapy: Diskussionen zur Postmenopausalen ... Foundation Symposium Proceedings, 13)

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£76 today · cheaper than every other day in the last 1 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 37 days • 37 data points

Historical
Generating forecast...
£77.86 £76.23 £76.59 £76.94 £77.30 £77.65 £78.01 01 May 2026 10 May 2026 19 May 2026 28 May 2026 06 June 2026

Price Distribution

Price distribution over 37 days • 2 price levels

Days at Price
Current Price
13 days · current 24 days 0 6 12 18 24 £76 £78 Days at Price

Price Analysis

Most common price: £78 (24 days, 64.9%)

Price range: £76 - £78

Price levels: 2 different prices over 37 days

Description

This volume contains an advanced level discussion on the appropriateness of hormone replacement therapy (HRT) in modern postmenopausal women on the basis of evidence provided by recent epidemiological studies. It addresses all aspects of benefits and risks associated with HRT. It focuses, however, on cancer risk and on risk of breast cancer in particular. The book advocates further epidemiological studies which incorporate pathobiological assessments. From the Back Cover Die Vor- und Nachteile der Hormonersatztherapie (HRT) werden von einer Expertengruppe hinsichtlich der epidemiologischen Beweislage diskutiert. Den Diskussionsschwerpunkt bildet jedoch die Problematik des Brustkrebsrisikos. Unter anderem wird gezeigt, dass die aus epidemiologischen Studien abgeleiteten Ergebnisse sich nicht mit den Wachstumseigenschaften dieser Tumoren decken, so dass weiterführende Bevölkerungsuntersuchungen unter Einbeziehung pathobiologischen Sachverstands notwendig erscheinen. The benefits and risks of hormone replacement therapy (HRT) are discussed by a group of experts with a view towards the evidence provided by recent epidemiological studies. Although all aspects of HRT indications and contra-indications are reviewed, the particular emphasis of this discussion is on breast cancer. Among other things, it is shown that the evidence on breast cancer provided in epidemiological studies does not match the growth characteristics of the tumours, and that further population research incorporating pathobiological assessments is required.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 November 2014
Listed Since
17 December 2014

Barcode

No barcode data available

Similar Products You Might Like

Hormonal Carcinogenesis: Proceedings of the First International Symposium
84% match

Hormonal Carcinogenesis: Proceedings of the First International Symposium

Springer

£77.72 03 Jun 2026
Hormonal Pathology of the Uterus: 1242 (Advances in Experimental Medicine and Biology, 1242)
82% match

Hormonal Pathology of the Uterus: 1242 (Advances in Experimental Medicine and Biology, 1242)

Springer

£86.90 05 Jun 2026
Hormones and Cancer: 138 (Advances in Experimental Medicine and Biology, 138)
81% match

Hormones and Cancer: 138 (Advances in Experimental Medicine and Biology, 138)

Springer

£77.33 26 May 2026
Hormone Receptors in Breast Cancer: 147 (Cancer Treatment and Research, 147)
81% match

Hormone Receptors in Breast Cancer: 147 (Cancer Treatment and Research, 147)

Springer

£80.64 18 May 2026
Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)
80% match

Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)

Springer

£103.24 06 Jun 2026
Endocrine Therapy of Breast Cancer VI (ESO Monographs)
80% match

Endocrine Therapy of Breast Cancer VI (ESO Monographs)

Springer

£76.38 01 Jun 2026
Approaches to Breast Cancer Prevention: 62 (Developments in Oncology, 62)
79% match

Approaches to Breast Cancer Prevention: 62 (Developments in Oncology, 62)

Springer

£146.35 25 May 2026
Endocrine Therapies in Breast and Prostate Cancer: 39 (Cancer Treatment and Research, 39)
79% match

Endocrine Therapies in Breast and Prostate Cancer: 39 (Cancer Treatment and Research, 39)

Springer

£113.76 26 May 2026
Non-Disseminated Breast Cancer: Controversial Issues in Management (Medical Radiology)
79% match

Non-Disseminated Breast Cancer: Controversial Issues in Management (Medical Radiology)

Springer

£76.38 30 May 2026
Adjuvant Therapy of Breast Cancer: 60 (Cancer Treatment and Research, 60)
79% match

Adjuvant Therapy of Breast Cancer: 60 (Cancer Treatment and Research, 60)

Springer

£149.65 26 May 2026
Breast Cancer Risk Reduction and Early Detection
78% match

Breast Cancer Risk Reduction and Early Detection

Springer

£79.70 05 Jun 2026
Prognostic variables in node-negative and node-positive breast cancer
78% match

Prognostic variables in node-negative and node-positive breast cancer

Springer

£174.86 26 May 2026
Environment and Breast Cancer
78% match

Environment and Breast Cancer

Springer

£107.98 06 Jun 2026
Breast Cancer: Origins, Detection, and Treatment: Proceedings of the International Breast Cancer Research Conference London, United Kingdom ― March 24–28, 1985: 43 (Developments in Oncology, 43)
78% match

Breast Cancer: Origins, Detection, and Treatment: Proceedings of the International Breast Cancer Research Conference London, United Kingdom ― March 24–28, 1985: 43 (Developments in Oncology, 43)

Springer

£77.95 25 May 2026
Biostatistical Applications in Cancer Research: 113 (Cancer Treatment and Research, 113)
78% match

Biostatistical Applications in Cancer Research: 113 (Cancer Treatment and Research, 113)

Springer

£141.52 02 Jun 2026
Diseases of the Breast during Pregnancy and Lactation: 1252 (Advances in Experimental Medicine and Biology, 1252)
78% match

Diseases of the Breast during Pregnancy and Lactation: 1252 (Advances in Experimental Medicine and Biology, 1252)

Springer

£93.13 05 Jun 2026
The Management of the Menopause & Post-Menopausal Years: The Proceedings of the International Symposium held in London 24–26 November 1975 Arranged by ... and Gynaecology, The University of London
78% match

The Management of the Menopause & Post-Menopausal Years: The Proceedings of the International Symposium held in London 24–26 November 1975 Arranged by ... and Gynaecology, The University of London

Springer

£78.30 25 May 2026
Hormone Therapy and Castration Resistance of Prostate Cancer
77% match

Hormone Therapy and Castration Resistance of Prostate Cancer

Springer

£81.58 06 Jun 2026
Hormone Therapy and Castration Resistance of Prostate Cancer
77% match

Hormone Therapy and Castration Resistance of Prostate Cancer

Springer

£106.99 12 May 2026
Atypical Breast Proliferative Lesions and Benign Breast Disease
77% match

Atypical Breast Proliferative Lesions and Benign Breast Disease

Springer

£64.53 22 May 2026
The Etiology of Human Breast Cancer: Endocrine, Genetic, Viral, Immunologic and Other Considerations
77% match

The Etiology of Human Breast Cancer: Endocrine, Genetic, Viral, Immunologic and Other Considerations

Springer

£77.23 22 May 2026
Endocrine Oncology (Contemporary Endocrinology)
77% match

Endocrine Oncology (Contemporary Endocrinology)

Humana

£73.10 27 May 2026
Women’s Health and Menopause: Risk Reduction Strategies ― Improved Quality of Health: 13 (Medical Science Symposia Series, 13)
77% match

Women’s Health and Menopause: Risk Reduction Strategies ― Improved Quality of Health: 13 (Medical Science Symposia Series, 13)

Springer

£113.94 18 May 2026
Integrative Medicine for Breast Cancer: An Evidence-Based Assessment
77% match

Integrative Medicine for Breast Cancer: An Evidence-Based Assessment

Springer

£65.57 25 May 2026